These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32251949)

  • 1. Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy.
    van Rijn-Dekker MI; van den Bosch L; van den Hoek JGM; Bijl HP; van Aken ESM; van der Hoorn A; Oosting SF; Halmos GB; Witjes MJH; van der Laan HP; Langendijk JA; Steenbakkers RJHM
    Radiother Oncol; 2020 Jun; 147():103-110. PubMed ID: 32251949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of sarcopenia in locally advanced head and neck cancer treated with chemoradiation: An Indian tertiary care hospital experience.
    Nagpal P; Pruthi DS; Pandey M; Yadav A; Singh H
    Oral Oncol; 2021 Oct; 121():105483. PubMed ID: 34403887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of sarcopenia on survival and treatment tolerance in patients with head and neck cancer treated with chemoradiotherapy.
    Bentahila R; Giraud P; Decazes P; Kreps S; Nay P; Chatain A; Fabiano E; Durdux C
    Cancer Med; 2023 Feb; 12(4):4170-4183. PubMed ID: 36263581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of sarcopenia on acute radiation-induced toxicity in head and neck cancer patients.
    Karavolia E; van Rijn-Dekker MI; Van den Bosch L; van den Hoek JGM; Oldehinkel E; Meijer TWH; Halmos GB; Witjes MJH; Oosting SF; van der Hoorn A; Langendijk JA; Steenbakkers RJHM
    Radiother Oncol; 2022 May; 170():122-128. PubMed ID: 35304862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of sarcopenia on tolerance of radiation and outcome in patients with head and neck cancer receiving chemoradiation.
    Ganju RG; Morse R; Hoover A; TenNapel M; Lominska CE
    Radiother Oncol; 2019 Aug; 137():117-124. PubMed ID: 31085391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer.
    Jung AR; Roh JL; Kim JS; Kim SB; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2019 Jul; 116():98-106. PubMed ID: 31185387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma.
    Nishikawa D; Hanai N; Suzuki H; Koide Y; Beppu S; Hasegawa Y
    ORL J Otorhinolaryngol Relat Spec; 2018; 80(1):1-9. PubMed ID: 29393251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Evaluation of Sarcopenia in Head and Neck Cancer Patients Treated with Radiotherapy or Radiochemotherapy.
    Thureau S; Lebret L; Lequesne J; Cabourg M; Dandoy S; Gouley C; Lefebvre L; Mallet R; Mihailescu SD; Moldovan C; Rigal O; Veresezan O; Modzewelski R; Clatot F
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33670339
    [No Abstract]   [Full Text] [Related]  

  • 9. Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly?
    Haehl E; Rühle A; David H; Kalckreuth T; Sprave T; Stoian R; Becker C; Knopf A; Grosu AL; Nicolay NH
    Radiat Oncol; 2020 Feb; 15(1):31. PubMed ID: 32019576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of sarcopenia and myosteatosis on survival outcomes for patients with head and neck cancer undergoing curative-intent treatment.
    Ahern E; Brown TE; Campbell L; Hughes BGM; Banks M; Lin CY; Kenny LM; Bauer J
    Br J Nutr; 2023 Feb; 129(3):406-415. PubMed ID: 35152926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Sarcopenia With Oncologic Outcomes of Primary Surgery or Definitive Radiotherapy Among Patients With Localized Oropharyngeal Squamous Cell Carcinoma.
    Olson B; Edwards J; Stone L; Jiang A; Zhu X; Holland J; Li R; Andersen P; Krasnow S; Marks DL; Clayburgh D
    JAMA Otolaryngol Head Neck Surg; 2020 Aug; 146(8):714-722. PubMed ID: 32525518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia and Systemic Inflammation Synergistically Impact Survival in Oral Cavity Cancer.
    Lee J; Liu SH; Dai KY; Huang YM; Li CJ; Chen JC; Leu YS; Liu CJ; Chen YJ
    Laryngoscope; 2021 May; 131(5):E1530-E1538. PubMed ID: 33135827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcopenia as a Prognostic Marker in Elderly Head and Neck Squamous Cell Carcinoma Patients Undergoing (Chemo-)Radiation.
    Haehl E; Alvino L; Rühle A; Zou J; Fabian A; Grosu AL; Nicolay NH
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study.
    Bentzen J; Toustrup K; Eriksen JG; Primdahl H; Andersen LJ; Overgaard J
    Acta Oncol; 2015 Jul; 54(7):1001-7. PubMed ID: 25629651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Skeletal Muscle Mass Is a Risk Factor for Aspiration Pneumonia During Chemoradiotherapy.
    Endo K; Ueno T; Hirai N; Komori T; Nakanishi Y; Kondo S; Wakisaka N; Yoshizaki T
    Laryngoscope; 2021 May; 131(5):E1524-E1529. PubMed ID: 33030229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal muscle mass is an imaging biomarker for decreased survival in patients with oropharyngeal squamous cell carcinoma.
    Chargi N; Bril SI; Swartz JE; Wegner I; Willems SM; de Bree R
    Oral Oncol; 2020 Feb; 101():104519. PubMed ID: 31855705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
    Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
    JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent radiotherapy plus epidermal growth factor receptor inhibitors in patients with human papillomavirus-related head and neck cancer.
    Pajares B; Perez-Villa L; Trigo JM; Toledo MD; Alvarez M; Jimenez B; Medina JA; de Luque V; Jerez JM; Alba E
    Clin Transl Oncol; 2014 Apr; 16(4):418-24. PubMed ID: 24193865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the soft palate dose regarding normal tissue toxicities in older adults with head and neck cancer undergoing definitive radiotherapy.
    Bitz HC; Sachpazidis I; Zou J; Schnell D; Baltas D; Grosu AL; Nicolay NH; Rühle A
    Radiat Oncol; 2024 Apr; 19(1):53. PubMed ID: 38689338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.